171 related articles for article (PubMed ID: 33120166)
21. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
Wu R; Zhai Y; Fearon ER; Cho KR
Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
[TBL] [Abstract][Full Text] [Related]
22. Alternate molecular genetic pathways in ovarian carcinomas of common histological types.
Willner J; Wurz K; Allison KH; Galic V; Garcia RL; Goff BA; Swisher EM
Hum Pathol; 2007 Apr; 38(4):607-13. PubMed ID: 17258789
[TBL] [Abstract][Full Text] [Related]
23. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality.
Anglesio MS; Wang YK; Maassen M; Horlings HM; Bashashati A; Senz J; Mackenzie R; Grewal DS; Li-Chang H; Karnezis AN; Sheffield BS; McConechy MK; Kommoss F; Taran FA; Staebler A; Shah SP; Wallwiener D; Brucker S; Gilks CB; Kommoss S; Huntsman DG
J Natl Cancer Inst; 2016 Jun; 108(6):djv428. PubMed ID: 26832771
[TBL] [Abstract][Full Text] [Related]
24. Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach.
Wu RC; Veras E; Lin J; Gerry E; Bahadirli-Talbott A; Baras A; Ayhan A; Shih IM; Wang TL
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 29162652
[TBL] [Abstract][Full Text] [Related]
25. High frequency of beta-catenin mutations in borderline endometrioid tumours of the ovary.
Oliva E; Sarrió D; Brachtel EF; Sánchez-Estévez C; Soslow RA; Moreno-Bueno G; Palacios J
J Pathol; 2006 Apr; 208(5):708-13. PubMed ID: 16429393
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma.
Schlosshauer PW; Pirog EC; Levine RL; Ellenson LH
Mod Pathol; 2000 Oct; 13(10):1066-71. PubMed ID: 11048799
[TBL] [Abstract][Full Text] [Related]
27. Endometrioid carcinoma of uterus and ovary.
Ghosh S; Bhattacharyya S; Datta C; Bhattacharya S; Dhar A
J Indian Med Assoc; 2004 Jul; 102(7):381-2. PubMed ID: 15717585
[TBL] [Abstract][Full Text] [Related]
28. Triple simultaneous primary gynecological malignancies in a 56-year-old patient.
Işin Doğan Ekici A; Küçükali T; Coşkun Salman M; Ayhan A
Int J Gynecol Cancer; 2006; 16(5):1947-50. PubMed ID: 17009998
[TBL] [Abstract][Full Text] [Related]
29. DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
Hsu Lin L; Allison DHR; Turashvili G; Vasudevaraja V; Tran I; Serrano J; Weigelt B; Ladanyi M; Abu-Rustum NR; Snuderl M; Chiang S
Mod Pathol; 2023 Nov; 36(11):100321. PubMed ID: 37652400
[TBL] [Abstract][Full Text] [Related]
30. Synchronous carcinomas of endometrium and ovary.
Piura B; Glezerman M
Gynecol Oncol; 1989 May; 33(2):261-4. PubMed ID: 2703187
[TBL] [Abstract][Full Text] [Related]
31. Synchronous squamous cell carcinoma of the endometrium and endometrioid adenocarcinoma of the ovary.
Grigoriadis C; Androutsopoulos G; Zygouris D; Arnogiannaki N; Terzakis E
Eur J Gynaecol Oncol; 2012; 33(6):666-8. PubMed ID: 23327069
[TBL] [Abstract][Full Text] [Related]
32. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
[TBL] [Abstract][Full Text] [Related]
33. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
Thai TH; Du F; Tsan JT; Jin Y; Phung A; Spillman MA; Massa HF; Muller CY; Ashfaq R; Mathis JM; Miller DS; Trask BJ; Baer R; Bowcock AM
Hum Mol Genet; 1998 Feb; 7(2):195-202. PubMed ID: 9425226
[TBL] [Abstract][Full Text] [Related]
35. The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas.
Zhan X; Li L; Wu M; Lang J
Arch Gynecol Obstet; 2019 Oct; 300(4):1045-1052. PubMed ID: 31520260
[TBL] [Abstract][Full Text] [Related]
36. Synchronous endometrioid carcinoma of the uterine corpus and ovary. A case report and review of the literature.
Grammatoglou X; Skafida E; Glava C; Katsamagkou E; Delliou E; Vasilakaki T
Eur J Gynaecol Oncol; 2009; 30(4):437-9. PubMed ID: 19761140
[TBL] [Abstract][Full Text] [Related]
37. Synchronous dual primary ovarian and endometrial carcinomas.
Pearl ML; Johnston CM; Frank TS; Roberts JA
Int J Gynaecol Obstet; 1993 Dec; 43(3):305-12. PubMed ID: 7907042
[TBL] [Abstract][Full Text] [Related]
38. Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Cybulska P; Paula ADC; Tseng J; Leitao MM; Bashashati A; Huntsman DG; Nazeran TM; Aghajanian C; Abu-Rustum NR; DeLair DF; Shah SP; Weigelt B
Gynecol Oncol; 2019 Sep; 154(3):516-523. PubMed ID: 31340883
[TBL] [Abstract][Full Text] [Related]
39. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
40. Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.
Turashvili G; Gómez-Hidalgo NR; Flynn J; Gonen M; Leitao MM; Soslow RA; Murali R
Gynecol Oncol; 2019 Jan; 152(1):38-45. PubMed ID: 30413340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
